SESEN BIO INC's ticker is SESN and the CUSIP is 817763105. A total of 44 filers reported holding SESEN BIO INC in Q2 2019. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13,775 | -95.2% | 22,600 | -93.6% | 0.00% | -100.0% |
| Q4 2021 | $288,000 | -84.0% | 353,185 | -84.4% | 0.00% | -80.0% |
| Q3 2021 | $1,801,000 | -85.9% | 2,270,118 | -17.9% | 0.01% | -85.3% |
| Q2 2021 | $12,780,000 | +65.0% | 2,766,318 | -7.1% | 0.03% | +61.9% |
| Q1 2021 | $7,746,000 | +697.7% | 2,979,218 | +314.3% | 0.02% | +600.0% |
| Q4 2020 | $971,000 | +392.9% | 719,018 | +412.1% | 0.00% | +200.0% |
| Q3 2020 | $197,000 | +497.0% | 140,418 | +203.2% | 0.00% | – |
| Q2 2020 | $33,000 | +65.0% | 46,318 | +29.3% | 0.00% | – |
| Q1 2020 | $20,000 | -28.6% | 35,818 | +32.5% | 0.00% | – |
| Q4 2019 | $28,000 | +154.5% | 27,040 | +156.6% | 0.00% | – |
| Q1 2019 | $11,000 | -26.7% | 10,536 | 0.0% | 0.00% | – |
| Q4 2018 | $15,000 | -75.4% | 10,536 | -62.8% | 0.00% | – |
| Q3 2018 | $61,000 | -35.1% | 28,336 | -41.0% | 0.00% | – |
| Q2 2018 | $94,000 | – | 48,036 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,523,296 | $16,175,000 | 0.87% |
| Avoro Capital Advisors LLC | 6,800,000 | $14,620,000 | 0.67% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 4,445,557 | $9,558,000 | 0.67% |
| NEXTHERA CAPITAL LP | 1,177,000 | $2,531,000 | 0.48% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 3,623,957 | $7,792,000 | 0.24% |
| SPHERA FUNDS MANAGEMENT LTD. | 630,000 | $1,355,000 | 0.16% |
| Schonfeld Strategic Advisors LLC | 778,100 | $1,673,000 | 0.07% |
| Castle Hook Partners LP | 1,012,924 | $2,178,000 | 0.06% |
| MYDA Advisors LLC | 50,000 | $108,000 | 0.06% |
| DRW Securities, LLC | 250,100 | $538,000 | 0.03% |